UY31059A1 - Formulaciones de aminoacido n-halogenado - Google Patents

Formulaciones de aminoacido n-halogenado

Info

Publication number
UY31059A1
UY31059A1 UY31059A UY31059A UY31059A1 UY 31059 A1 UY31059 A1 UY 31059A1 UY 31059 A UY31059 A UY 31059A UY 31059 A UY31059 A UY 31059A UY 31059 A1 UY31059 A1 UY 31059A1
Authority
UY
Uruguay
Prior art keywords
amino acid
halogenated amino
acid formulations
transfer agent
phase transfer
Prior art date
Application number
UY31059A
Other languages
English (en)
Inventor
Dassanayake Nissanke
Stroman David
Masood A Chowhan
Weslwy Wehsin Han
Larry Wayane Schneider
Original Assignee
Alcon Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Res Ltd filed Critical Alcon Res Ltd
Publication of UY31059A1 publication Critical patent/UY31059A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/14—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds containing nitrogen-to-halogen bonds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N41/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom
    • A01N41/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom containing a sulfur-to-oxygen double bond
    • A01N41/04—Sulfonic acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/02—Ammonia; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pest Control & Pesticides (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Plant Pathology (AREA)
  • Inorganic Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

El presente invento se refiere a un método para el tratamiento de infecciones en tejidos que comprende poner en contacto el tejido infectado con una cantidad farmacéuticamente eficaz de una formulacion que contiene un aminoácido N-halogenado y un agente de transferencia de fase. Asimismo, la presente memoria describe una formulacion con actividad antimicrobiana que contiene un aminoácido N-halogenado y un agente de transferncia de fase.
UY31059A 2007-05-01 2008-04-29 Formulaciones de aminoacido n-halogenado UY31059A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91529107P 2007-05-01 2007-05-01

Publications (1)

Publication Number Publication Date
UY31059A1 true UY31059A1 (es) 2008-10-31

Family

ID=39596568

Family Applications (1)

Application Number Title Priority Date Filing Date
UY31059A UY31059A1 (es) 2007-05-01 2008-04-29 Formulaciones de aminoacido n-halogenado

Country Status (16)

Country Link
US (1) US20080275123A1 (es)
EP (1) EP2139518A1 (es)
JP (1) JP2010526082A (es)
KR (1) KR20100017166A (es)
CN (1) CN101674849A (es)
AR (1) AR066373A1 (es)
AU (1) AU2008245455A1 (es)
BR (1) BRPI0810790A2 (es)
CA (1) CA2684098A1 (es)
CL (1) CL2008001279A1 (es)
MX (1) MX2009011819A (es)
RU (1) RU2009144292A (es)
TW (1) TW200902093A (es)
UY (1) UY31059A1 (es)
WO (1) WO2008134687A1 (es)
ZA (1) ZA200907050B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY31058A1 (es) * 2007-05-01 2008-10-31 Alcon Res Ltd Formulaciones de aminoacido n-halogenado con compuestos antiinflamatorios
EP2265267B1 (en) 2008-04-10 2016-09-21 Waldemar Gottardi Compositions comprising n-halogenated or n, n-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections
WO2009127924A1 (en) * 2008-04-15 2009-10-22 Waldemar Gottardi Compositions and devices for antisepsis and anticoagulation
KR20110043661A (ko) * 2008-08-12 2011-04-27 노바베이 파마슈티칼즈, 인코포레이티드 항미생물 젤 제형물
WO2010091280A1 (en) * 2009-02-06 2010-08-12 Alcon Research, Ltd. N-halogenated amino acid formulations comprising phosphine or amine oxides
CN102625558B (zh) * 2012-03-30 2014-09-03 安徽航天环境工程有限公司 带有冷却系统的等离子体加热器

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2003198C (en) * 1988-11-29 1995-03-21 Anthony J. Dziabo, Jr. Aqueous ophthalmic solutions and method for preserving same
US5320805A (en) * 1991-05-15 1994-06-14 Sterilex Corporation Methods of using a cleaner, sanitizer, disinfectant, fungicide, sporicide, chemical sterilizer
US5421818A (en) * 1993-10-18 1995-06-06 Inner Ear Medical Delivery Systems, Inc. Multi-functional inner ear treatment and diagnostic system
US6156728A (en) * 1996-11-01 2000-12-05 Genentech, Inc. Treatment of inner ear hair cells
US5968986A (en) * 1997-12-18 1999-10-19 Woodward Laboratories, Inc. Antimicrobial nail coating composition
US6759434B2 (en) * 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
BRPI0413660A (pt) * 2003-08-18 2006-10-24 Novacal Pharmaceuticals Inc Aminoácidos n,n-di-alogenado e derivados
TWI386201B (zh) * 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法

Also Published As

Publication number Publication date
AR066373A1 (es) 2009-08-12
ZA200907050B (en) 2010-12-29
WO2008134687A1 (en) 2008-11-06
AU2008245455A1 (en) 2008-11-06
CL2008001279A1 (es) 2009-01-02
BRPI0810790A2 (pt) 2015-06-16
TW200902093A (en) 2009-01-16
CA2684098A1 (en) 2008-11-06
US20080275123A1 (en) 2008-11-06
KR20100017166A (ko) 2010-02-16
CN101674849A (zh) 2010-03-17
JP2010526082A (ja) 2010-07-29
MX2009011819A (es) 2009-11-13
EP2139518A1 (en) 2010-01-06
RU2009144292A (ru) 2011-06-10

Similar Documents

Publication Publication Date Title
CL2014000601A1 (es) Composición tópica veterinaria que comprende al menos un agente activo derivado de isoxazolina; y uso de la composición para el tratamiento o prevención de una infestación o infección por parásitos en un animal.
BRPI0414581C1 (pt) composto, composição farmacêutica compreendendo o referido composto e uso do referido composto
BRPI0822885A2 (pt) Implemento para cuidado oral, método para administrar um agente ativo, e, kit para cuidado oral
EA201170876A1 (ru) Применение способной к вспениванию композиции, по существу, не содержащей фармацевтически активные ингредиенты, для лечения кожи человека
UY31059A1 (es) Formulaciones de aminoacido n-halogenado
BR112012006010A2 (pt) composto de glicina
UY30158A1 (es) Uso de derivados de benzo-heteroaril sulfamida para el tratamiento del dolor
BRPI0910759A2 (pt) sistema e método para dispensar um agente de benefício hidrofóbicos a um substrato queratinoso, e, composição de enxágue corporal
CR20140005A (es) Una nueva composición terapéutica que contiene apomorfina como principio activo
BR112012007798A2 (pt) microcápsulas estáveis e composição para aplicação tópica e método para a preparação de microcápsulas
CL2013002700A1 (es) Cápsula suave ingerible que contiene inositol y excipientes, o inositol, excipientes y al menos un principio activo adicional, tal como ácido fólico, polifenoles de cocoa, genisteína, l-arginina, vitamina e, selenio, n-acetilcisteína y melatonina; útil para el tratamiento del ovario poliquístico, resistencia a la insulina y otros
CO6551731A2 (es) Composiciòn de combinaciòn que comprende como ingrediente activo l- carnitina o propionil l- carnitina, para la prevenciòn o tratamiento de insuficienca venosa crònica
AR090874A1 (es) Formulacion
CO6280474A2 (es) Composicion farmaceutica para el tratamiento de la eyaculacion precoz
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
BR122020011180B8 (pt) formulações injetáveis de compostos de tetraciclina
EP2361083A4 (en) COMPOSITION FOR THE TREATMENT OF EPITHELIAL TISSUE
UY31058A1 (es) Formulaciones de aminoacido n-halogenado con compuestos antiinflamatorios
CL2011001829A1 (es) 3'-n-desmetil-4''-o-(2-dietilaminoetanoil)-6-o-metil-9a-aza-9a-homoeritromicina a, sus sales y formas cristalinas 1, 2 y 3; proceso de preparacion; uso para tratar enfermedades inflamatorias; composicion farmaceutica; y composicion que ademas comprende otro compuesto activo.
WO2013092457A3 (de) Wirkstoffkombinationen aus einer oder mehreren carbonsäuren, insbesondere hydroxycarbonsäuren, und einer oder mehreren physiologisch unbedenklichen hydroxamsäure sowie kosmetische oder dermatologische zubereitungen, solche wirkstoffkombinationen enthaltend
CL2008001281A1 (es) Metodo para limpiar y/o desinfectar un lente de contacto; formulacion para desinfectar un lente de contacto que comprende un amonoacido n-halogenado y un agente de transferencia de fase; composicion farmaceutica que comprende un aminoacido n-halogenado y un agente de transferencia de fase; y metodo para desinfectar o limpiar superficies
CO6290762A2 (es) Nuevos derivados quinazolin-2, 4-diona y una composicion farmaceutica para prevenir a tratar la enfermedad neurocerebral
CL2009000065A1 (es) Proteina aislada que comprende una pluralidad de dominios rrl para utilizarse como agente anti-microbiano; composicion farmaceutica que comprende dicha proteina aislada; metodo para tratar infeccion microbiana.
UY31057A1 (es) Formulaciones de aminoacido n-halogenado que contiene acido alifatico
CO6660504A2 (es) Agente terapeutico de liberacion sostenida para la hipertensión y la disfunción renal

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20190711